Factors Affecting the Difficulty of Laparoscopic D2 Lymph Node Dissection for Gastric Cancer

Laparoscopic D2 lymph node dissection (LND) for gastric cancer has a wide range of operations and a high degree of difficulty.The purpose of this study was to evaluate the relationship between clinicopathological factors and the difficulty of laparoscopic D2 LND.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Surgery-Complications

Sex eligibility

All sexes

Study type

Observational

Primary location

Department of Gastric Surgery

Fuzhou, Fujian, China

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

all patients undergoing laparoscopic surgery
Laparoscopic system is 2D and has complete D2 lymph node dissection.

Exclusion criteria

patients undergoing laparotomy
incomplete video or clinicopathological information

Treatment and study plan

Whether lymph node dissection is qualified or not

Other

Klass-02-QC LND scale and general error score tool were used to quantitatively evaluate the intraoperative performance of D2 LND

Primary outcomes

surgery complicated

Time frame: 30 days after operation

Incidence of operative complications between qualified group and unqualified group

Sponsors and collaborators

Lead sponsor

Fujian Medical University

Other

Registry information

Official study title

Factors Affecting the Difficulty of Laparoscopic D2 Lymph Node Dissection for Gastric Cancer:a Retrospective Cohort Study

Important dates

Study start: 2022
Primary completion: 2022
Study completion: 2022
First posted: Oct 18, 2022
Registry last updated: Oct 18, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed